Sign In
Buy HUM
$349.89
+22.35 (+6.82%)
At Close: Jun 04, 2026
HUM Investors Have Opportunity to Lead Humana Inc. Securities Fraud Lawsuit
10:15am, Thursday, 01'st Aug 2024
LOS ANGELES, Aug. 1, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the
Humana Slides on Profitability Concerns Despite Q2 Earnings Beat
08:36am, Thursday, 01'st Aug 2024
Humana Inc. NYSE: HUM is a leading health insurer predominantly focused on Medicare Advantage plans, serving millions of individuals and families nationwide. The company's business model centers on of
Humana Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - HUM
09:30pm, Wednesday, 31'st Jul 2024
NEW YORK, NY / ACCESSWIRE / July 31, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the
Levi & Korsinsky Reminds Humana Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 2, 2024 - HUM
03:30pm, Wednesday, 31'st Jul 2024
NEW YORK, NY / ACCESSWIRE / July 31, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the
IMMINENT HUM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Humana Inc. Investors to Join the Class Action Lawsuit!
03:00pm, Wednesday, 31'st Jul 2024
NEW YORK, NY / ACCESSWIRE / July 31, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Humana Inc. ("Hu
Humana (HUM) Q2 Earnings Beat on Medicare Advantage Strength
02:21pm, Wednesday, 31'st Jul 2024
Humana's (HUM) second-quarter results reflect overall premium growth and a well-performing CenterWell unit, partly offset by elevated costs. It expects individual MA membership to record growth of 225
Shareholders that lost money on Humana Inc. (HUM) should contact Levi & Korsinsky about pending Class Action - HUM
01:30pm, Wednesday, 31'st Jul 2024
NEW YORK, NY / ACCESSWIRE / July 31, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the
Class Action Filed Against Humana Inc. (HUM) Seeking Recovery for Investors - Contact Levi & Korsinsky
01:30pm, Wednesday, 31'st Jul 2024
NEW YORK, NY / ACCESSWIRE / July 31, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Humana Inc. (HUM)
01:02pm, Wednesday, 31'st Jul 2024
LOS ANGELES, July 31, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 2, 2024 deadline to file a lead plaintiff motion in the class action fi
NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Humana Inc. ("Humana" or the "Company") (NYSE: HUM) of a class action securities lawsuit.
Humana, Inc. (HUM) Q2 2024 Earnings Call Transcript
12:30pm, Wednesday, 31'st Jul 2024
Humana, Inc. (NYSE:HUM ) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Lisa Stoner - Vice President, Investor Relations James Rechtin - President and Chief Executive O
Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics
10:37am, Wednesday, 31'st Jul 2024
The headline numbers for Humana (HUM) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humana
10:05am, Wednesday, 31'st Jul 2024
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Humana To Contact Him Directly To Discuss Their Options If you suf
Humana (HUM) Surpasses Q2 Earnings and Revenue Estimates
08:45am, Wednesday, 31'st Jul 2024
Humana (HUM) came out with quarterly earnings of $6.96 per share, beating the Zacks Consensus Estimate of $5.89 per share. This compares to earnings of $8.94 per share a year ago.
